Published by Alexander Bueso on 20th November 2020
(Sharecast News) - The Food and Drug Administration has granted Emergency Use Approval for baricitinib, a treatment for Covid-19 developed jointly by Eli Lilly and Incyte, in combination with Gilead Sciences's remdesivir.
URL: http://www.digitallook.com/dl/news/story/31466266/...